Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Orbital filariasis.

PMID: 35282899
Journal: MEDICINA CLINICA
Year: 2022
Reference: Med Clin (Barc). 2022 Jul 8;159(1):56. doi: 10.1016/j.medcli.2022.02.004. Epub 2022 Mar 10.
Impact factor:
Publication type: Paper in national publication
Authors: Garrido-Marin, Marta; Sanchez-Dalmau, Bernardo F; Sanchez-Vela, Laura et al.
DOI: 10.1016/j.medcli.2022.02.004

Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study.

PMID: 36644590
Journal: Journal of bone and joint infection
Year: 2022
Reference: J Bone Jt Infect. 2022 Dec 21;7(6):279-288. doi: 10.5194/jbji-7-279-2022. eCollection 2022.
Impact factor:
Publication type: Paper in international publication
Authors: Ariza, Javier; Benito, Natividad; Blanco Garcia, Antonio; Bonnet, Eric; Chan, Monica; Del Toro, Maria Dolores; Giannitsioti, Efthymia; Kocak Tufan, Zeliha; Los-Arcos, Ibai; Mavrogenis, Andreas et al.
DOI: 10.5194/jbji-7-279-2022

Outbreaks of Gastroenteritis Due to Norovirus in Schools and Summer Camps in Catalonia, 2017-2019.

PMID: 35543555
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Jun 29;10(3):e0011922. doi: 10.1128/spectrum.00119-22. Epub 2022 May 11.
Impact factor: 7.171
Publication type: Paper in international publication
Authors: Parron, Ignacio, Barrabeig, Irene, Soldevila, Nuria, Bartolome, Rosa, Guix, Susana, Rius, Cristina, Cornejo-Sanchez, Thais, Izquierdo, Conchita, Dominguez, Angela et al.
DOI: 10.1128/spectrum.00119-22

Outbreaks of Gastroenteritis Due to Norovirus in Schools and Summer Camps in Catalonia, 2017-2019.

PMID: 35543555
Journal: Microbiology Spectrum
Year: 2022
Reference: Microbiol Spectr. 2022 Jun 29;10(3):e0011922. doi: 10.1128/spectrum.00119-22. Epub 2022 May 11.
Impact factor:
Publication type: Paper in international publication
Authors: Barrabeig, Irene; Bartolome, Rosa; Cornejo-Sanchez, Thais; Dominguez, Angela; Guix, Susana; Izquierdo, Conchita; Parron, Ignacio; Rius, Cristina; Soldevila, Nuria et al.
DOI: 10.1128/spectrum.00119-22

Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

PMID: 35702878
Journal: AMERICAN JOURNAL OF HEMATOLOGY
Year: 2022
Reference: Am J Hematol. 2022 Aug;97(8):E312-E317. doi: 10.1002/ajh.26626. Epub 2022 Jun 28.
Impact factor: 10.047
Publication type: Letter or abstract
Authors: Sciume, Mariarita, Bilgin, Yavuz M, Falces-Romero, Iker, Jimenez, Moraima, Ormazabal-Velez, Irati, Weinbergerova, Barbora, DulerY, Remy, Stojanoski, Zlate, Lahmer, Tobias, Fernandez, Noemi et al.
DOI: 10.1002/ajh.26626

Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

PMID: 35702878
Journal: AMERICAN JOURNAL OF HEMATOLOGY
Year: 2022
Reference: Am J Hematol. 2022 Aug;97(8):E312-E317. doi: 10.1002/ajh.26626. Epub 2022 Jun 28.
Impact factor:
Publication type: Letter or abstract
Authors: Ammatuna, Emanuele; Aujayeb, Avinash; Bailen-Almorox, Rebeca; Bergantim, Rui; Besson, Caroline; Biernat, Monika M; Bilgin, Yavuz M; Blennow, Ola; Bonanni, Matteo; Brones, Clara et al.
DOI: 10.1002/ajh.26626

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

PMID: 35081472
Journal: Transplantation and cellular therapy
Year: 2022
Reference: Transplant Cell Ther. 2022 Apr;28(4):187.e1-187.e10. doi: 10.1016/j.jtct.2022.01.017. Epub 2022 Jan 23.
Impact factor: 0
Publication type: Paper in international publication
Authors: Battiwalla, Minoo, Bredeson, Chris, Cerny, Jan, Chhabra, Saurabh, Deol, Abhinav, Diaz, Miguel Angel, Farhadfar, Nosha, Freytes, Cesar, Gajewski, James, Gandhi, Manish J et al.
DOI: 10.1016/j.jtct.2022.01.017

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

PMID: 35081472
Journal: Transplantation and Cellular Therapy
Year: 2022
Reference: Transplant Cell Ther. 2022 Apr;28(4):187.e1-187.e10. doi: 10.1016/j.jtct.2022.01.017. Epub 2022 Jan 23.
Impact factor:
Publication type: Paper in international publication
Authors: Abid, Muhammad Bilal; Ahn, Kwang Woo; Aljurf, Mahmoud; Alkhateeb, Hassan B; Awan, Farrukh T; Bacher, Ulrike; Badawy, Sherif M; Bal, Susan; Battiwalla, Minoo; Bredeson, Chris et al.
DOI: 10.1016/j.jtct.2022.01.017

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome.

PMID: 34226786
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jun;58(6):520-522. doi: 10.1016/j.arbres.2021.05.027. Epub 2021 Jun 18.
Impact factor: 4.872
Publication type: Letter whit IF
Authors: Pericas, Juan M, Cilloniz, Catia, Peroni, Hector, Torres, Antoni, Gabarrus, Albert, Barbeta, Enric et al.
DOI: 10.1016/j.arbres.2021.05.027

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome.

PMID: 34226786
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jun;58(6):520-522. doi: 10.1016/j.arbres.2021.05.027. Epub 2021 Jun 18.
Impact factor:
Publication type: Letter whit IF
Authors: Barbeta, Enric; Cilloniz, Catia; Gabarrus, Albert; Pericas, Juan M; Peroni, Hector; Torres, Antoni et al.
DOI: 10.1016/j.arbres.2021.05.027

Outcomes of Patients with Severe Obesity and Cirrhosis with Portal Hypertension Undergoing Bariatric Surgery: a Systematic Review.

PMID: 36422758
Journal: OBESITY SURGERY
Year: 2022
Reference: Obes Surg. 2022 Nov 24. doi: 10.1007/s11695-022-06362-9.
Impact factor:
Publication type: Review in international publication
Authors: Angel, Mariana; Banares, Juan; Ciudin, Andreea; Comas, Marta; Flores, Vanesa; Manzano-Nunez, Ramiro; Pericas, Juan M; Rivera-Esteban, Jesus; Vilallonga, Ramon et al.
DOI: 10.1007/s11695-022-06362-9

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.

PMID: 35660139
Journal: LANCET ONCOLOGY
Year: 2022
Reference: Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.
Impact factor: 41.316
Publication type: Paper in international publication
Authors: Earnshaw, Irina, Handford, Jasmine, Sita-Lumsden, Ailsa, Apthorp, Eleanor, Vincenzi, Bruno, Bertuzzi, Alexia, Brunet, Joan, Lambertini, Matteo, Maluquer, Clara, Pedrazzoli, Paolo et al.
DOI: 10.1016/S1470-2045(22)00273-X

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.

PMID: 35660139
Journal: LANCET ONCOLOGY
Year: 2022
Reference: Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar-Company, Juan; Andaleeb, Ramis; Apthorp, Eleanor; Apthorp, Eleanor; Aujayeb, Avinash; Baggi, Alice; Bain, Hamish Dc; Bawany, Samira; Belessiotis, Katherine; Benafif, Sarah et al.
DOI: 10.1016/S1470-2045(22)00273-X

Outcomes of two circular external fixation systems in the definitive treatment of acute tibial fracture related infections.

PMID: 36028372
Journal: INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
Year: 2022
Reference: Injury. 2022 Oct;53(10):3438-3445. doi: 10.1016/j.injury.2022.08.037. Epub 2022 Aug 18.
Impact factor:
Publication type: Paper in international publication
Authors: Corona, Pablo S; de Albert, Matias; Maestre Cano, Domingo; Martinez Ros, Javier; Pujol, Oriol; Ricou, Elisenda; Salcedo Canovas, Cesar; Vicente, Matias et al.
DOI: 10.1016/j.injury.2022.08.037

Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria.

PMID: 36172059
Journal: Open Forum Infectious Diseases
Year: 2022
Reference: Open Forum Infect Dis. 2022 Aug 30;9(9):ofac442. doi: 10.1093/ofid/ofac442. eCollection 2022 Sep.
Impact factor:
Publication type: Paper in international publication
Authors: Abad, Nuria Fernandez; Acebal, Juan Galvez; Adan, Ivan; Adell, Marta Matamala; Alamo, Elena Pisos; Alcolea, Eva Cascales; Alda, Rosa Sebastian; Alegre, Oriol; Alejandro, Ubeda Iglesias; Almazan, Amaya Jimeno et al.
DOI: 10.1093/ofid/ofac442

OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery.

PMID: 36058743
Journal: Gynecologic Oncology
Year: 2022
Reference: Gynecol Oncol. 2022 Oct;167(1):22-27. doi: 10.1016/j.ygyno.2022.08.004. Epub 2022 Sep 2.
Impact factor:
Publication type: Paper in international publication
Authors: Angeles, Martina Aida; Cappucio, Serena; Cascales-Campos, Pedro Antonio; Chacon, Enrique; Chiva, Luis; Del, Mathilde; Domingo, Santiago; Fagotti, Anna; Ferron, Gwenael; Fotopoulou, Christina et al.
DOI: 10.1016/j.ygyno.2022.08.004

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

PMID: 35576508
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 May 16:JCO2102660. doi: 10.1200/JCO.21.02660.
Impact factor: 44.544
Publication type: Paper in international publication
Authors: Viteri, Santiago, Pereira, Eva, Royuela, Ana, Calvo, Virginia, Martin-Lopez, Javier, Garcia-Garcia, Francisco, Casarrubios, Marta, Franco, Fernando, Sanchez-Herrero, Estela, Massuti, Bartomeu et al.
DOI: 10.1200/JCO.21.02660

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

PMID: 35576508
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 Sep 1;40(25):2924-2933. doi: 10.1200/JCO.21.02660. Epub 2022 May 16.
Impact factor:
Publication type: Paper in international publication
Authors: Barneto Aranda, Isidoro; Bernabe Caro, Reyes; Calvo, Virginia; Casal Rubio, Joaquin; Casarrubios, Marta; Cobo, Manuel; Cruz-Bermudez, Alberto; De Castro Carpeno, Javier; Del Barco, Edel; Domine, Manuel et al.
DOI: 10.1200/JCO.21.02660

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer.

PMID: 36228963
Journal: ANNALS OF ONCOLOGY
Year: 2022
Reference: Ann Oncol. 2022 Oct 10. pii: S0923-7534(22)04165-5. doi: 10.1016/j.annonc.2022.09.159.
Impact factor:
Publication type: Paper in international publication
Authors: Aktan, G; Arahmani, A; Armstrong, A C; Arnedos, M; Balmana, J; Bergh, J; Bliss, J; Brufsky, A M; Cameron, D; Campbell, C et al.
DOI: 10.1016/j.annonc.2022.09.159

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

PMID: 35834777
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 Jul 14:JCO2101604. doi: 10.1200/JCO.21.01604.
Impact factor: 44.544
Publication type: Paper in international publication
Authors: Golan, Talia, Locker, Gershon Y, Cui, Karen, McGuinness, David, Bordia, Sonal, O'Reilly, Eileen M, Tortora, Giampaolo, Reinacher-Schick, Anke, Oh, Do-Youn, Arnold, Dirk et al.
DOI: 10.1200/JCO.21.01604

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

PMID: 35834777
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2022
Reference: J Clin Oncol. 2022 Dec 1;40(34):3929-3939. doi: 10.1200/JCO.21.01604. Epub 2022 Jul 14.
Impact factor:
Publication type: Paper in international publication
Authors: Algul, Hana; Arnold, Dirk; Bordia, Sonal; Cui, Karen; Golan, Talia; Hall, Michael J; Hammel, Pascal; Hochhauser, Daniel; Kindler, Hedy L; Locker, Gershon Y et al.
DOI: 10.1200/JCO.21.01604

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

PMID: 35417652
Journal: JOURNAL OF MEDICINAL CHEMISTRY
Year: 2022
Reference: J Med Chem. 2022 Apr 28;65(8):6070-6087. doi: 10.1021/acs.jmedchem.1c01941. Epub 2022 Apr 13.
Impact factor: 7.446
Publication type: Paper in international publication
Authors: Alarcon, Helena, Slobodnyuk, Konstantin, Cano-Galietero, Marta, Fuentes, Pedro, Guijarro, Pedro J, Munoz, Maria Jose, Suarez-Cabrera, Leticia, Santamaria, Anna, Estrada-Tejedor, Roger, Borrell, Jose I et al.
DOI: 10.1021/acs.jmedchem.1c01941

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

PMID: 35417652
Journal: JOURNAL OF MEDICINAL CHEMISTRY
Year: 2022
Reference: J Med Chem. 2022 Apr 28;65(8):6070-6087. doi: 10.1021/acs.jmedchem.1c01941. Epub 2022 Apr 13.
Impact factor:
Publication type: Paper in international publication
Authors: Alarcon, Helena; Borrell, Jose I; Bou-Petit, Elisabeth; Cano-Galietero, Marta; Estrada-Tejedor, Roger; Fuentes, Pedro; Guijarro, Pedro J; Hummer, Stefan; Munoz, Maria Jose; Ramon Y Cajal, Santiago et al.
DOI: 10.1021/acs.jmedchem.1c01941

Overdiagnosis and overtreatment - More is better?

PMID: 35914721
Journal: CIRUGIA ESPANOLA
Year: 2022
Reference: Cir Esp (Engl Ed). 2022 Dec;100(12):793-794. doi: 10.1016/j.cireng.2022.06.053. Epub 2022 Jul 29.
Impact factor:
Publication type: Letter or abstract
Authors: Garcia-Alamino, Josep M; Lopez-Cano, Manuel et al.
DOI: 10.1016/j.cireng.2022.06.053

Publications

Publications searcher

Orbital filariasis.

Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study.

Outbreaks of Gastroenteritis Due to Norovirus in Schools and Summer Camps in Catalonia, 2017-2019.

Outbreaks of Gastroenteritis Due to Norovirus in Schools and Summer Camps in Catalonia, 2017-2019.

Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome.

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome.

Outcomes of Patients with Severe Obesity and Cirrhosis with Portal Hypertension Undergoing Bariatric Surgery: a Systematic Review.

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.

Outcomes of two circular external fixation systems in the definitive treatment of acute tibial fracture related infections.

Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria.

OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery.

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer.

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

Overdiagnosis and overtreatment - More is better?

Patronage:

Collaborating:

Accreditations: